KCPG
Kavar Capital Partners Group’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,497
| Closed | -$703K | – | 184 |
|
|
2024
Q4 | $703K | Sell |
9,497
-1,380
| -13% | -$102K | 0.12% | 105 |
|
|
2024
Q3 | $718K | Sell |
10,877
-1,417
| -12% | -$93.5K | 0.11% | 108 |
|
|
2024
Q2 | $1.14M | Sell |
12,294
-1,090
| -8% | -$101K | 0.2% | 88 |
|
|
2024
Q1 | $1.28M | Sell |
13,384
-14,764
| -52% | -$1.41M | 0.24% | 82 |
|
|
2023
Q4 | $2.15M | Buy |
28,148
+7,309
| +35% | +$557K | 0.24% | 81 |
|
|
2023
Q3 | $1.44M | Sell |
20,839
-1,245
| -6% | -$86.3K | 0.31% | 75 |
|
|
2023
Q2 | $2.08M | Sell |
22,084
-527
| -2% | -$49.7K | 0.44% | 64 |
|
|
2023
Q1 | $1.87M | Sell |
22,611
-470
| -2% | -$38.9K | 0.4% | 66 |
|
|
2022
Q4 | $1.72M | Sell |
23,081
-4,270
| -16% | -$319K | 0.4% | 67 |
|
|
2022
Q3 | $2.26M | Buy |
27,351
+209
| +0.8% | +$17.3K | 0.58% | 52 |
|
|
2022
Q2 | $2.58M | Buy |
27,142
+1,163
| +4% | +$111K | 0.6% | 50 |
|
|
2022
Q1 | $3.06M | Buy |
25,979
+143
| +0.6% | +$16.8K | 0.66% | 44 |
|
|
2021
Q4 | $3.35M | Buy |
25,836
+481
| +2% | +$62.3K | 0.7% | 44 |
|
|
2021
Q3 | $2.87M | Buy |
25,355
+235
| +0.9% | +$26.6K | 0.65% | 46 |
|
|
2021
Q2 | $2.6M | Buy |
25,120
+715
| +3% | +$74.1K | 0.63% | 48 |
|
|
2021
Q1 | $2.04M | Buy |
24,405
+145
| +0.6% | +$12.1K | 0.55% | 60 |
|
|
2020
Q4 | $2.21M | Buy |
24,260
+15,870
| +189% | +$1.45M | 0.64% | 49 |
|
|
2020
Q3 | $670K | Buy |
8,390
+705
| +9% | +$56.3K | 0.23% | 84 |
|
|
2020
Q2 | $531K | Buy |
+7,685
| New | +$531K | 0.2% | 85 |
|